Suppr超能文献

各种唑类药物对引起外阴阴道念珠菌病的念珠菌属的药敏模式。

Susceptibility pattern of various azoles against Candida species causing vulvovaginal candidiasis.

作者信息

Dharmik Preeti G, Gomashe A V, Upadhyay V G

机构信息

Department of Microbiology, Shri Shivaji Science College, Nagpur, 440012 Maharashtra India.

出版信息

J Obstet Gynaecol India. 2013 Apr;63(2):135-7. doi: 10.1007/s13224-012-0280-3. Epub 2012 Nov 2.

Abstract

OBJECTIVES

Vulvovaginal candidiasis (VVC) is a common gynecological finding among the women worldwide. Candida species are often less susceptible to antifungal agents. Owing to this fact, in this study, we aimed at assessing the prevalence rate and antimicrobial susceptibility pattern of various azoles against Candida species causing VVC in symptomatic women.

METHODS

The prospective study included 217 female patients with symptoms of vaginal discharges. Specimens were characterized microscopically and were subjected to antimicrobial susceptibility testing against various azoles according to NCCLSM44 disk-diffusion method.

RESULTS

VVC was detected in 18.4 % of the cases. Based on age distribution, the highest rate of Candida infection was observed in the age group of 20-29 years (42.5 %). Antifungal susceptibility revealed that fluconazole was highly effective against Candida Species (97.2 %); on the contrary, the highest resistance was observed in the case of miconazole (63 %).

CONCLUSION

In the current study, prevalence rate of VVC was found to be 18.4 %, and among the various azoles tested, fluconazole has the highest antimicrobial activity.

摘要

目的

外阴阴道念珠菌病(VVC)是全球女性中常见的妇科病症。念珠菌属对抗真菌药物往往不太敏感。鉴于此,在本研究中,我们旨在评估有症状女性中引起VVC的各种念珠菌属的患病率以及各种唑类药物的抗菌药敏模式。

方法

这项前瞻性研究纳入了217例有阴道分泌物症状的女性患者。对标本进行显微镜检查,并根据NCCLSM44纸片扩散法对各种唑类药物进行抗菌药敏试验。

结果

18.4%的病例检测出VVC。根据年龄分布,念珠菌感染率最高的是20 - 29岁年龄组(42.5%)。抗菌药敏结果显示,氟康唑对念珠菌属高度有效(97.2%);相反,咪康唑的耐药率最高(63%)。

结论

在本研究中,VVC的患病率为18.4%,在所测试的各种唑类药物中,氟康唑具有最高的抗菌活性。

相似文献

1
Susceptibility pattern of various azoles against Candida species causing vulvovaginal candidiasis.
J Obstet Gynaecol India. 2013 Apr;63(2):135-7. doi: 10.1007/s13224-012-0280-3. Epub 2012 Nov 2.
9
A study on biofilm production and antifungal drug resistance among Candida species from vulvovaginal and bloodstream infections.
Infect Drug Resist. 2018 Nov 23;11:2443-2448. doi: 10.2147/IDR.S179462. eCollection 2018.
10
Molecular identification and antifungal susceptibility of 186 Candida isolates from vulvovaginal candidiasis in southern China.
J Med Microbiol. 2015 Apr;64(Pt 4):390-393. doi: 10.1099/jmm.0.000024. Epub 2015 Jan 16.

引用本文的文献

1
Resistance to Fluconazole of Candida albicans in Vaginal Isolates: a 10-Year Study in a Clinical Referral Center.
Antimicrob Agents Chemother. 2023 May 17;67(5):e0018123. doi: 10.1128/aac.00181-23. Epub 2023 Apr 24.
2
Antifungal profile of vulvovaginal candidiasis in sexually active females from a tertiary care hospital of Western Rajasthan.
J Family Med Prim Care. 2021 Jan;10(1):398-402. doi: 10.4103/jfmpc.jfmpc_1124_20. Epub 2021 Jan 30.
5
The effect of vaginal cream containing ginger in users of clotrimazole vaginal cream on vaginal candidiasis.
J Adv Pharm Technol Res. 2017 Apr-Jun;8(2):80-84. doi: 10.4103/japtr.JAPTR_176_16.

本文引用的文献

3
Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases.
J Clin Microbiol. 2005 May;43(5):2155-62. doi: 10.1128/JCM.43.5.2155-2162.2005.
5
Treatment of vaginitis caused by Candida glabrata: use of topical boric acid and flucytosine.
Am J Obstet Gynecol. 2003 Nov;189(5):1297-300. doi: 10.1067/s0002-9378(03)00726-9.
6
Candida albicans secreted aspartyl proteinases in virulence and pathogenesis.
Microbiol Mol Biol Rev. 2003 Sep;67(3):400-28, table of contents. doi: 10.1128/MMBR.67.3.400-428.2003.
7
Vulvovaginal carriage of yeasts other than Candida albicans.
Sex Transm Infect. 2003 Jun;79(3):249-50. doi: 10.1136/sti.79.3.249.
9
Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis.
Obstet Gynecol. 2002 Mar;99(3):419-25. doi: 10.1016/s0029-7844(01)01759-8.
10
Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes.
BMC Infect Dis. 2002;2:1. doi: 10.1186/1471-2334-2-1. Epub 2002 Jan 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验